AdeTherapeutics Inc
Our patented products address complications related to surgery and ageing and set standard of care for clinicians, hospitals and patients.
- Stage Full Product Ready
- Industry Biotechnology
- Location Canada
- Currency USD
- Founded November 2006
- Employees 5
- Website adetherapeutics.com
Company Summary
Our world class scientific team and leading global partners translate over 30 international held patents (IP) to develop standard of care drugs and medical devices in various surgical specialties. The products are administered during surgery and prevent conditions, such as fibrosis or scar tissue, that are responsible for 1 in3 re-admissions into hospitals and numerous complications for the patient. We sell/license our IP to biotech or pharma.
Team
-
Lynne RoberstonEVP Regulatory Affairs & Clinical Development
25 years of pharmaceutical experience
MS, PhD (Pharmacology)
EVP Regulatory Affairs, AdeTherapeutics inc (25 years plus experience)
Director of Regulatory Affairs, Quintiles
Vice President Operations, Norstrum Pharmaceuticals
Director Project Management, KOS Pharmaceuticals
Senior Director of Business and Product Development, Schering-Plough
Project Manager, Mylan Technologies -
Sanj SinghPresident & CEO
Co-founder and has led AdeTherapeutics Inc. from inception; attracted world class team and built key strategic partnerships with multi-national companies, raised capital to bring an idea from university labs into Phase II and expanded IP portfolio to include additional opportunities.
Entrepreneurial start-up experience ;
Vice-Chair of the Emerging Companies Advisory Board, BioteCanada, Ottawa, ON
Advisors
-
WMCZ, Mark Dolan and Craig ZwadaLawyerUnconfirmedDeloitte, Blair Knippel, Humphrey TamAccountantUnconfirmedJennifer Fox, BS, MS, JDIP CounselUnconfirmed
Previous Investors
-
AgWest Commercialization FundUnconfirmedGroup of private investors-names available upon requestUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.